SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C/A - Offering Statement: [Amend]
SEC Accession No. 0001669191-19-000029
Filing Date
2019-01-29
Accepted
2019-01-29 10:21:07
Documents
9

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C/A  
1 primary_doc.xml C/A 10806
2 OFFERING STATEMENT PDF offeringstatement.pdf EX-99 170033
3 OFFERING PAGE JPG offeringpage.jpg GRAPHIC 2086521
4 CPA REVIEW REPORT reviewletter.pdf EX-99 169194
5 CERTIFICATE OF INCORPORATION certificateofincorporation.PDF EX-99 1762347
6 CORPORATE BYLAWS corporatebylaws.pdf EX-99 123173
7 PITCH DECK pitchdeck.pdf EX-99 4034031
8 ADDITIONAL INFORMATION otherfinancial.pdf EX-99 140687
9 IMAGE ATTACHMENTS HTML imageattachments.htm EX-99 244
  Complete submission text file 0001669191-19-000029.txt   11695867
Mailing Address 999 WEST 1500 SOUTH BUILDING 600 WOODS CROSS UT 84087
Business Address 999 WEST 1500 SOUTH, BUILDING 600 WOODS CROSS UT 84087 8014200285
Phoenix PharmaLabs Inc (Filer) CIK: 0001755778 (see all company filings)

IRS No.: 731626743 | State of Incorp.: UT | Fiscal Year End: 1231
Type: C/A | Act: 33 | File No.: 020-24785 | Film No.: 19547432